US 11299517
Recombinant vaccine against Marek's disease and Newcastle disease
granted A61KA61K2039/543A61K2039/552
Quick answer
US patent 11299517 (Recombinant vaccine against Marek's disease and Newcastle disease) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/543, A61K2039/552, A61K38/00, A61K39/12